November 12, 2013 11:34 AM | 1 min read |
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
In a report published Tuesday, Citigroup analyst Liav Abraham reiterated a Buy rating on
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
(NASDAQ: ENDP), and raised the price target from $43.00 to $70.00.In the report, Citigroup noted, “We view Endo's proposed acquisition of Paladin as a highly strategic, innovative deal that: (i) augments the company's international presence in the specialty pharmaceuticals arena; (ii) improves cash flow generation, thereby strengthening Endo's balance sheet; and (iii) provides the company with an Irish domicile and an attractive tax rate, increasing the attractiveness of potential future acquisitions and enhancing the scope for M&A activities. We maintain our Buy rating.”Endo Health Solutions closed on Monday at $61.86.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.